Drugs / FMP30 Donor Stool
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03594487 | Nov 2018 → Dec 2024 | relapsing-remitting multiple sclerosis | Jeffrey Gelfand | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FMP30 Donor Stool | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03594487 ↗ |
| Route | Other | “will be administered via colonoscopy” NCT03594487 ↗ |